AGL 38.50 Decreased By ▼ -0.06 (-0.16%)
AIRLINK 211.50 Increased By ▲ 3.73 (1.8%)
BOP 9.88 Decreased By ▼ -0.18 (-1.79%)
CNERGY 6.67 Decreased By ▼ -0.41 (-5.79%)
DCL 9.59 Decreased By ▼ -0.40 (-4%)
DFML 40.43 Decreased By ▼ -0.71 (-1.73%)
DGKC 100.00 Decreased By ▼ -3.46 (-3.34%)
FCCL 35.20 Decreased By ▼ -1.15 (-3.16%)
FFBL 87.50 Decreased By ▼ -4.09 (-4.47%)
FFL 13.98 Decreased By ▼ -0.62 (-4.25%)
HUBC 133.49 Decreased By ▼ -5.94 (-4.26%)
HUMNL 14.00 Decreased By ▼ -0.10 (-0.71%)
KEL 5.67 Decreased By ▼ -0.30 (-5.03%)
KOSM 7.25 Decreased By ▼ -0.61 (-7.76%)
MLCF 46.00 Decreased By ▼ -1.28 (-2.71%)
NBP 66.38 Decreased By ▼ -7.38 (-10.01%)
OGDC 218.50 Decreased By ▼ -4.16 (-1.87%)
PAEL 39.00 Increased By ▲ 0.89 (2.34%)
PIBTL 8.96 Decreased By ▼ -0.31 (-3.34%)
PPL 198.20 Decreased By ▼ -7.65 (-3.72%)
PRL 40.40 Increased By ▲ 0.55 (1.38%)
PTC 25.80 Decreased By ▼ -0.82 (-3.08%)
SEARL 102.85 Decreased By ▼ -7.39 (-6.7%)
TELE 9.05 Decreased By ▼ -0.18 (-1.95%)
TOMCL 36.90 Decreased By ▼ -1.31 (-3.43%)
TPLP 14.05 Increased By ▲ 0.28 (2.03%)
TREET 25.40 Decreased By ▼ -1.05 (-3.97%)
TRG 58.40 Decreased By ▼ -2.14 (-3.53%)
UNITY 33.80 Decreased By ▼ -0.34 (-1%)
WTL 1.71 Decreased By ▼ -0.17 (-9.04%)
BR100 11,957 Decreased By -341.5 (-2.78%)
BR30 37,521 Decreased By -1356 (-3.49%)
KSE100 111,611 Decreased By -3249.6 (-2.83%)
KSE30 35,071 Decreased By -1124.8 (-3.11%)
World

EU regulator 'convinced' AstraZeneca jab benefits outweigh risks

  • The suspensions have provoked intense debate over whether it was prudent to put AstraZeneca inoculations on hold just as vaccination campaigns were beginning to gather pace.
Published March 17, 2021

THE HAGUE: The EU's medicines regulator said Tuesday it was "firmly convinced" the benefits of AstraZeneca's vaccine outweigh potential risks, insisting there was no evidence linking it to blood clots after several nations suspended the shot over health fears.

The suspensions have provoked intense debate over whether it was prudent to put AstraZeneca inoculations on hold just as vaccination campaigns were beginning to gather pace.

Experts at both the World Health Organization and the European Medicines Agency (EMA) met Tuesday to discuss the vaccine, with the European organisation expected to publish conclusions Thursday.

While millions of doses of the vaccine developed with Oxford University have been administered, small numbers of people have developed blood clots, prompting countries including the EU's three largest nations -- Germany, France and Italy -- to suspend injections.

The EMA insisted that countries should continue using the vaccine.

"We are still firmly convinced that the benefits of the AstraZeneca vaccine in preventing Covid-19 with its associated risk of hospitalisation and death outweigh the risk of these side effects," EMA chief Emer Cooke said Tuesday.

Cooke noted however that the regulator was "looking at adverse events associated with all vaccines".

France and Italy welcomed the news.

The preliminary statements from the EMA "are encouraging," read a joint statement from French President Emmanuel Macron and Italian Prime Minister Mario Draghi.

French Prime Minister Jean Castex vowed he would be vaccinated "very quickly" with the AstraZeneca vaccine to give the public confidence in the jab if it is ruled as safe by the EU medicines agency.

Castex also said that new restrictions could be put in place for the Paris region, such as the weekend lockdowns already imposed in the Nice and Calais regions.

"We are in a worrying and critical situation and, clearly, measures of the type that have been used in other parts of the territory are on the table," he told BFM TV in a live interview.

Comments

Comments are closed.